2010
DOI: 10.1084/jem.20100876
|View full text |Cite
|
Sign up to set email alerts
|

Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis

Abstract: Cyclin-dependent kinase 5 drives T cell activation and disease in EAE in part by regulating the actin binding protein coronin 1a.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
57
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
3
3

Relationship

2
4

Authors

Journals

citations
Cited by 58 publications
(58 citation statements)
references
References 62 publications
1
57
0
Order By: Relevance
“…Female C57BL/6J (B6; H-2 b ) and B6D2F1 (F1; H-2 bxd ) mice aged 8 to 12 weeks were purchased from The Jackson Laboratory (Bar Harbor, ME). Detailed methods for the generation of Cdk5-null hematopoietic chimeras, 13 immunoprecipitation and Cdk5 kinase activity assay, 25 T-cell isolation and BM transplant (BMT) procedures, 33 mixed lymphocyte reactions, T-cell proliferation and cytolytic activity, 33,34 assessment of clinical 35 and target organ GVHD, 33 in vivo graft-versus-leukemia (GVL) models, 33,34 bioluminescent imaging techniques, 34,36 and statistical analysis have been previously described and are outlined in supplemental Methods (available on the Blood Web site).…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…Female C57BL/6J (B6; H-2 b ) and B6D2F1 (F1; H-2 bxd ) mice aged 8 to 12 weeks were purchased from The Jackson Laboratory (Bar Harbor, ME). Detailed methods for the generation of Cdk5-null hematopoietic chimeras, 13 immunoprecipitation and Cdk5 kinase activity assay, 25 T-cell isolation and BM transplant (BMT) procedures, 33 mixed lymphocyte reactions, T-cell proliferation and cytolytic activity, 33,34 assessment of clinical 35 and target organ GVHD, 33 in vivo graft-versus-leukemia (GVL) models, 33,34 bioluminescent imaging techniques, 34,36 and statistical analysis have been previously described and are outlined in supplemental Methods (available on the Blood Web site).…”
Section: Methodsmentioning
confidence: 99%
“…33,34,37,38 We first assessed whether enhanced Cdk5 activity could be detected during early stages of GVHD as described in supplemental Methods. 13 Cdk5 activity was notably increased by day 10 after allo-HCT in the spleen and small intestine, established sites of activation, and initial recruitment of donor T cells (Figure 2A HCT (Figure 2B-C; P , .01). These findings were accompanied by a reduction in donor T-cell expansion on days 3, 7, and 14 in alloCdk5 2/2C recipients ( Figure 2D) correlating with decreases in day 7 serum interferon g (IFNg) levels ( Figure 2E) and significant reductions in inflammation in key GVHD target organs ( Figure 2F).…”
Section: /2cmentioning
confidence: 98%
See 3 more Smart Citations